Selpercatinib as the Guardian of the Central Nervous System for Patients With RET Fusion-Positive NSCLC? Lau SCM, Ou SI. J Thorac Oncol 2023;18:561-563.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lau SCM, Ou SI. Selpercatinib as the Guardian of the Central Nervous System for Patients With RET Fusion-Positive NSCLC? J Thorac Oncol 2023;18:561-563.
PMID: 37087118